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Background: Patients suffer from thalassemia and chronic
renal failure on maintenance hemodialysis; have been
exposed to blood-born infections, especially hepatitis C due
to long-term transfusion. Recently, hepatitis C is one of the
main health concerns in these patients. The aim of this study
was to determine the prevalence of hepatitis C and related
risk factors in thalassemic and hemodialysis patients in Ker-
man province of Iran.
Methods: in this cross-sectional we have totally examined
384 patients (203 hemodialysis cases and 181 thalassemia
cases) by RT-PCR in Kerman. The information was obtained
by question are then followed by blood sampled obtaining
and RT-PCR. Statistical analysis were done using t-test and
Chi-square methods
Results: We found that 130 cases out of 384 were infected
by HCV. Our ﬁnding also showed that 16 cases were female
(17%) while we found 114 (83%) cases of infected male
patients
Conclusions: The prevalence of hepatitis C infection is
very high in thalassemia and hemodialysis patients and based
on other studies our results showed that the prevalence of
HCV infection in Kerman is more than other provinces of
Iran. Hepatitis C in these patients, is more higher in Kerman
province than other provinces of Iran.
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Hepatitis C virus (HCV) infection has become a signiﬁ-
cant public health problem in Southern China. Guangxi is
one of the provinces hardest hit by the virus. Molecular epi-
demiology of HCV infection in injection drug users (IDUs) in
Guangxi Province would be important for understanding the
epidemiology and be beneﬁcial for improving prevention and
control.
Methods: IDUs were recruited from Liuzhou methadone
clinic, Guangxi, Southern China. Blood samples were col-
lected. HIV and HCV serology was determined. HCV RNA was
extracted and NS5B region was ampliﬁed using RT-PCR. HCV
genotype was determined by phylogenetic analysis (MEGA
3.0).
Results: A total of 96 samples yielded adequate PCR prod-
uct for sequencing and genotyping (86%). Twenty subjects
were HIV/HCV coinfected, and 76 were HCV monoinfected.
Overall, subtype 6a (46%) was predominant, followed by
3a (20%) and 3b (16%). There was no signiﬁcant difference
in HCV genotype distribution between HIV/HCV coinfection
group and HCV monoinfection group (p > 0.05). The genetic
distance of genotype 6 between individuals is shorter than
that of other genotypes.
Conclusion: Genotype 6a is the predominant of HCV in
IDUs in Southern China. It represents a relatively recent
introduction of the genotype to the region. Because of the
needle-sharing in IDUs in South-eastern Asia and the higher
rate of viral mutation, more subtypes may be identiﬁed.
Phylogenetic analysis shows the even distribution of HCV
sequences in coinfection group and monoinfection group.
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Hepatitis B virus (HBV) infection is endemic in Africa.
As many as 98% of black Africans are infected during their
lives and about 10% (65 million) have chronic HBV infection,
which is the cause of 70—80% of all hepatocellular carci-
noma (HCC) cases. Despite this high prevalence of HBV and
the high incidence of HCC in Africa, relatively few complete
HBV genomes from African HCC cases have been deposited
in international data bases. In order to gain a clearer under-
standing of the role of genetic variants and mutants in
the development of HCC, the complete genomes of HBV
isolated from southern African HCC patients were ampli-
ﬁed and molecularly characterized. HBV DNA was extracted
from forty HBsAg-positive HCC patients. Twenty six complete
genomes were successfully ampliﬁed, cloned and sequenced
from nine HCC patients. Phylogenetic analyses of the com-
plete genomes and the individual open reading frames of
HBV isolates from the HCC patients, led to the classiﬁca-
tion of all the isolates within subgenotype A1. No isolates
belonging to subgenotype A2 and genotype D were identi-
ﬁed even though these genotypes/subgenotypes have been
shown to circulate in South Africa. Seventy-eight percent
of the patients carried HBV strains with the double basic
core promoter (BCP) mutation (1762T/1764A), previously
shown to reduce HBeAg expression. All ﬁve HBV genomes
isolated from one patient contained novel complex BCP
rearrangements, which introduced 2 HNF1 and 1 putative
HNF3 transcription factor binding sites. These mutations
can enhance viral replication and simultaneously abolish
